Zeposia approved for MS in Scotland Published: 10 February 2021 The Scottish Medicines Consortium (SMC) has approved the drug ozanimod (Zeposia) for patients with active relapsing remitting multiple sclerosis (RRMS).  The SMC has said ozanimod can be prescribed for people who are experiencing relapses or those whose MRI scans show